Dr Reddy's receives two USFDA observations for New York API...

Dr Reddy's receives two USFDA observations for New York API facility

Posted

110

Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe.

Read Full Article

Effettua l'accesso per mettere mi piace, condividere e commentare!

Business

Adani Defence & Aerospace partners with Sparton to manufacture indigenous sonobuoys, boost anti-submarine warfare capabilities

Adani Defence & Aerospace collaborates with Sparton to produce advanced anti-submarine warfare...

By 0 3

Business

India’s smartphone exports outpace petroleum, diamonds to top export chart

India's smartphone exports have surged, surpassing petroleum products and diamonds to become the...

By 0 3

International

Survivors fight to heal from rampant sexual violence in war-torn Sudan

When a fighter from Sudan's paramilitary Rapid Support Forces (RSF) stormed into Aisha's family...

By 0 20

National

No excuse for delaying climate action: Chief Secretary Aryal

KATHMANDU: Chief Secretary Eaknaryan Aryal has emphasized that there is no justification for...

By 0 26

National

'Won’t happen again, but you must stop too': Akhilesh Yadav reacts to SP’s 'objectionable' post on deputy CM Brajesh Pathak

By 0 39